je.st
news
Tag: vaccine
Fostera PCV MH Combination Vaccine Now Available from Zoetis
2013-11-14 01:00:00| ThePigSite - Industry News
US - Fostera™ PCV MH — the first and only one-bottle, one-dose combination vaccine that helps protect swine from porcine circovirus-associated disease (PCVAD) and enzootic pneumonia caused by Mycoplasma hyopneumoniae (M. hyo) — is now available from Zoetis. With its one-dose or two-dose protocol, the innovative formulation of Fostera PCV MH offers convenience and flexibility to swine managers.
Tags: combination
vaccine
pcv
combination vaccine
Elanco Expands Vaccine Presence With Titanium & Master Guard Purchase
2013-11-11 21:59:26| Beef
Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced the company will purchase the Titanium® and Master Guard® brands from AgriLabs®. These well-known cattle vaccine brands will complement Elanco’s growing vaccine portfolio, including the recently approved Viralign™ 6, the only modified-live combination vaccine to protect against bovine viral diarrhea (BVD) virus 1b, which is now the most predominant BVD virus strain in the United States. read more
Tags: purchase
master
presence
guard
Mercks Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study
2013-11-04 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Immunogenicity non-inferior to GARDASIL for original four HPV types Merck expects to file Biologics License Application with U.S. FDA in 2013 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in the pivotal Phase III efficacy study, its investigational 9-valent HPV vaccine (V503) prevented approximately 97 percent of cervical, vaginal and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58. Language: English Contact: Media:Pamela Eisele, 908-423-5042orImraan Munshi, 215-652-0059orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
additional
study
iii
ARS Makes Safer FMD Vaccine
2013-10-24 17:19:00| National Hog Farmer
Source: U.S. Department of Agriculture U.S. Department of Agriculture (USDA) scientists have devised a new patent-pending technology to safely produce foot-and-mouth disease (FMD) vaccines. A highly contagious disease, FMD affects cloven-hoofed animals such as cattle, swine, sheep and goats. The United States has not had an outbreak of FMD since 1929, but the disease is still prevalent in other countries, can be debilitating in adult animals, and can cause death in young animals. read more
Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices
2013-10-24 16:27:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today provided an overview of the clinical trial program for V503, the companys investigational 9-valent human papillomavirus (HPV) vaccine, to the Advisory Committee on Immunization Practices in the United States. Merck said that the pivotal efficacy trial is complete, the primary endpoints have been met and the company expects to submit a Biologics License Application for V503 to the U.S. Language: English Contact: MerckMedia:Pamela Eisele, (908) 423-5042Imraan Munshi, (215) 652-0059Investor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: update
committee
practices
advisory
Sites : [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] next »